T. Rowe Price Investment Management, Inc.
Position in CYTK — Cytokinetics Inc
CIK 1897612
BALTIMORE, MD
Position in CYTK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,154,996,294
+$29,298,018 QoQ
Shares Held
17,523,840
-1.1% QoQ
Ownership
14.1%
of shares outstanding
% of Portfolio
0.81%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 96.73908800810781.ToString("F0")%
Shared 0.ToString("F0")%
None 3.260911991892188.ToString("F0")%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026T. Rowe Price Investment Management, Inc. holds $11,176,949,825 across 48 Biotechnology names. CYTK ranks #3 (10.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,193,324 | $1,718,315,111 | |
| 2 | ASND |
Ascendis Pharma A/S
|
6,162,042 | $1,409,443,866 | |
| 3 | CYTK |
Cytokinetics Inc
This page
|
17,523,840 | $1,154,996,294 | |
| 4 | APGE |
Apogee Therapeutics, Inc.
|
10,300,984 | $867,033,823 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
12,126,017 | $704,642,847 | |
| 6 | DYN |
Dyne Therapeutics, Inc.
|
30,785,801 | $558,146,572 | |
| 7 | BNTX |
BioNTech SE
|
5,856,073 | $520,487,768 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
6,159,027 | $462,481,337 |
All Filings in CYTK
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,154,996,294 | 17,523,840 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,125,698,276 | 17,716,372 | Shares | Sole | 2026-02-19 | |
| 2025-09-30 | $1,048,664,060 | 19,080,496 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $581,584,617 | 17,602,440 | Shares | Sole | 2025-08-14 | |
| 2025-04-30 | $574,918,968 | 13,420,144 | Shares | Sole | 2025-05-07 | |
| 2025-03-31 | $400,101,537 | 9,955,251 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $505,779,865 | 10,752,123 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $511,631,313 | 9,689,987 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $440,953,519 | 8,138,677 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $359,074,604 | 5,121,589 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $186,139,702 | 2,229,485 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $53,504,839 | 1,816,186 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $58,856,787 | 1,804,316 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $53,420,601 | 1,518,062 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $21,244,259 | 463,646 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||